Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
These five pediatric cancer research fellows will receive funding for four years for their innovative project.
University of Colorado researchers target earlier diagnosis and treatment resistance with cutting-edge technology.
A conversation with Dr. Alexandra-Chloé Villani about side effects experienced by melanoma patients undergoing immunotherapy
This report highlights the estimated number of new cases, prevalence, and survival statistics for cancer in the United States.
Global call to action and release of the World Cancer Day 2024 Equity Report.
Strategies for oncology research community reflect urgent need to preserve, strengthen pandemic-era flexibilities.
Blood test uses cell-free DNA methylation to quantify tumor burden and more
The Leukemia & Lymphoma Society’s Lee Greenberger rounds up exciting study results from ASH 2023 and emerging themes for the future.
Research overseen by Rebecca Schweppe, PhD, proposes a new way of treating patients who are resistant to standard therapy.
Fred Hutch scientists prevent metastasis by boosting cancer-killing T cells in patients, primarily those with breast cancer.
We all have trillions of microorganisms that live throughout our bodies.
CAR-T expert Terry Fry of the University of Colorado Cancer Center talks about new data and future applications for this immunotherapy.
These important discoveries by ACS researchers will move us closer to a world without cancer.
Meningioma is a common type of primary brain tumor. The activity of 34 specific genes may help predict prognosis of the cancer.
Statistics can simultaneously enlighten and confuse people with cancer.
Announced on “Good Morning America,” the $400 million gift will transform MSK cancer care and help lead to a cure. [VIDEO]
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.